Original language | English |
---|---|
Pages (from-to) | 245-247 |
Number of pages | 3 |
Journal | Journal of Clinical Lipidology |
Volume | 15 |
Issue number | 2 |
DOIs | |
State | Published - Mar 1 2021 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of Clinical Lipidology, Vol. 15, No. 2, 01.03.2021, p. 245-247.
Research output: Contribution to journal › Editorial
TY - JOUR
T1 - Prevention
T2 - The past, present, and future of medicine and society
AU - Agarwala, Anandita
AU - Saeed, Anum
AU - Kulkarni, Saneel
AU - Goldberg, Anne
AU - Ballantyne, Christie
N1 - Funding Information: Disclosures: Anandita Agarwala: None, Anum Saeed: None, Saneel Kulkarni: None, Anne Goldberg: Honoraria; Modest; Esperion, Other; Modest; Merck, Other; Significant; National Lipid Association, Research Grant; Modest; Amarin, Amgen, Pfizer, Research Grant; Significant; Novartis, Regeneron, Sanofi, Ionis/Akcea. Christie Ballantyne: Grant/Research Support- All significant. (All paid to institution, not individual): Abbott Diagnostic, Akcea, Amgen, Esperion, Novartis, Regeneron, Roche Diagnostic, NIH, AHA, ADA. Consultant- Abbott Diagnostics, Althera, Amarin∗, Amgen, Arrowhead, Astra Zeneca, Corvidia, Denka Seiken∗, Esperion, Genentech, Gilead, Matinas BioPharma Inc, New Amsterdam∗, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche Diagnostic, Sanofi-Synthelabo∗. Funding Information: Disclosures: Anandita Agarwala: None, Anum Saeed: None, Saneel Kulkarni: None, Anne Goldberg: Honoraria; Modest; Esperion, Other; Modest; Merck, Other; Significant; National Lipid Association, Research Grant; Modest; Amarin, Amgen, Pfizer, Research Grant; Significant; Novartis, Regeneron, Sanofi, Ionis/Akcea. Christie Ballantyne: Grant/Research Support- All significant. (All paid to institution, not individual): Abbott Diagnostic, Akcea, Amgen, Esperion, Novartis, Regeneron, Roche Diagnostic, NIH, AHA, ADA. Consultant- Abbott Diagnostics, Althera, Amarin∗, Amgen, Arrowhead, Astra Zeneca, Corvidia, Denka Seiken∗, Esperion, Genentech, Gilead, Matinas BioPharma Inc, New Amsterdam∗, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche Diagnostic, Sanofi-Synthelabo∗.
PY - 2021/3/1
Y1 - 2021/3/1
UR - http://www.scopus.com/inward/record.url?scp=85100058806&partnerID=8YFLogxK
U2 - 10.1016/j.jacl.2020.12.013
DO - 10.1016/j.jacl.2020.12.013
M3 - Editorial
C2 - 33516696
AN - SCOPUS:85100058806
SN - 1933-2874
VL - 15
SP - 245
EP - 247
JO - Journal of Clinical Lipidology
JF - Journal of Clinical Lipidology
IS - 2
ER -